Search hospitals
>
Hawaii
>
Honolulu
Queen's Medical Center
Claim this profile
Honolulu, Hawaii 96813
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for HIV Infection
433 reported clinical trials
26 medical researchers
Summary
Queen's Medical Center is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, HIV Infection and other specialties. Queen's Medical Center is involved with conducting 433 clinical trials across 586 conditions. There are 26 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Jami A. Fukui, and Michael Carney, MD.
Area of expertise
Breast Cancer
Queen's Medical Center has run 71 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Queen's Medical Center has run 61 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Jeffrey L. Berenberg
Straub Clinic and Hospital
2 years of reported clinical research
Jared D. Acoba
Queen's Medical Center
3 years of reported clinical research
Jami A. Fukui
Kapiolani Medical Center for Women and Children
6 years of reported clinical research
Michael Carney, MD
Kapiolani Medical Center for Women and Children
6 years of reported clinical research
Clinical Trials running at Queen's Medical Center
Lung Cancer
Breast Cancer
Colorectal Cancer
Cancer
Breast cancer
Ovarian Cancer
Pancreatic Cancer
Non-Small Cell Lung Cancer
Esophageal cancer
Oropharyngeal Carcinoma
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting
2 awards
Phase 3
12 criteria
Durvalumab
for Lung Cancer
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.
Recruiting
2 awards
Phase 3
8 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Queen's Medical Center?
Queen's Medical Center is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, HIV Infection and other specialties. Queen's Medical Center is involved with conducting 433 clinical trials across 586 conditions. There are 26 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Jami A. Fukui, and Michael Carney, MD.
Where is Queen's Medical Center located?
To reach The Queen's Medical Center in Honolulu, take the I-1 East and exit onto Punchbowl Street. The hospital is located at 1301 Punchbowl Street. For parking, use the Miller Street or Punchbowl Street entrances to Miller Garage.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at Queen's Medical Center, please contact Patient Financial Services or the Business Services (Billing) department at 808-691-4210.
What insurance does Queen's Medical Center accept?
The Queen's Medical Center accepts most private health insurance plans. However, it does not accept Medicare HMO, Commercial HMO, and Kaiser health plans. For a comprehensive list of accepted insurance plans and to verify eligibility, please refer to The Queen's Health System's Financial Resources page.
What awards or recognition has Queen's Medical Center received?
The Queen's Medical Center in Honolulu, Hawaii, is renowned for its exceptional patient experience, earning the Healthgrades Outstanding Patient Experience Award in 2022. It is ranked as the #1 hospital in Hawai'i for 2022-2023 by U.S. News & World Report and is nationally recognized in the top 50 for gastroenterology and GI surgery, orthopedics, and cancer care. Additionally, it serves as a Level I Trauma Center and has been highlighted by Newsweek as one of the best hospitals in the United States in 2022.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.